Quetiapine for schizophrenia
75 results
1 - 75
Quetiapine for schizophrenia 
Quetiapine for schizophrenia Edited (no change to conclusions)- Quetiapine versus other atypical antipsychotics for schizophrenia: Cochrane systematic review
- Quetiapine versus typical antipsychotic medications for schizophrenia: Cochrane systematic review
- Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia New search for studies and content updated (no change to conclusions)
- Risperidone versus other atypical antipsychotics for schizophrenia Edited (no change to conclusions)
- Olanzapine versus other atypical antipsychotics for schizophrenia Edited (no change to conclusions)
- Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems
- Clozapine versus other atypical antipsychotics for schizophrenia Edited (no change to conclusions)
- Schizophrenia
- Clozapine versus other atypical antipsychotics for schizophrenia
- New generation antipsychotics for first episode schizophrenia
- Ziprasidone versus other atypical antipsychotics for schizophrenia Edited (no change to conclusions)
- Molindone for schizophrenia and severe mental illness: Cochrane systematic review
- Second-generation versus first-generation antipsychotic drugs for schizophrenia
- Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems Edited (no change to conclusions)
- Fluphenazine (oral) versus atypical antipsychotics for schizophrenia Edited (no change to conclusions)
- Chlorpromazine versus atypical antipsychotic drugs for schizophrenia New
- Risperidone vs. other atypical antipsychotic medication for schizophrenia
- Atypical antipsychotics for people with both schizophrenia and depression Edited (no change to conclusions)
- Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia
- Atypical antipsychotics for people with both schizophrenia and depression
- Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
- Loxapine for schizophrenia
- Amisulpride versus other atypical antipsychotics for schizophrenia Edited (no change to conclusions)
- Aripiprazole versus other atypical antipsychotics for schizophrenia: Cochrane systematic review
- Risperidone (depot) for schizophrenia New search for studies and content updated (conclusions changed)
- Antipsychotic drug treatment for elderly people with late‐onset schizophrenia Edited (no change to conclusions)
- Sertindole versus other atypical antipsychotics for schizophrenia Edited (no change to conclusions)
- Oral paliperidone for schizophrenia: Cochrane systematic review
- Loxapine for schizophrenia Edited (no change to conclusions)
- Bifeprunox versus placebo for schizophrenia New
- Amisulpride for schizophrenia Edited (no change to conclusions)
- Zotepine versus other atypical antipsychotics for schizophrenia Edited (no change to conclusions)
- New generation antipsychotics for first episode schizophrenia Edited (no change to conclusions)
- Risperidone for psychosis‐induced aggression or agitation (rapid tranquillisation)
- Newer atypical antipsychotic medication versus clozapine for schizophrenia: Cochrane systematic review
- Management of sexual dysfunction due to antipsychotic drug therapy New search for studies and content updated (no change to conclusions)
- Increasing antipsychotic dose for non response in schizophrenia New
- Psychosis in the elderly
- Depot risperidone for schizophrenia
- Risperidone versus other antipsychotics for people with severe mental illness and co‐occurring substance misuse Edited (no change to conclusions)
- Risperidone for psychosis‐induced aggression or agitation (rapid tranquillisation) New
- Aripiprazole for schizophrenia
- Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia New search for studies and content updated (conclusions changed)
- Adolescent psychosis
- Haloperidol dose for the acute phase of schizophrenia New search for studies and content updated (conclusions changed)
- Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Edited (no change to conclusions)